Serial examination of 20,248 newborn fetuses and infants: Correlations between drug exposure and major malformations

American Journal of Medical Genetics

Volumn 63, Issue 1, 1996, Pages 268-276

  Queißer Luft, Annette ^a   Eggers, Inez ^a   Stolz, Gabriela ^a   Kieninger Baum, Dorothee ^a   Schlaefer, Klaus ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

congenital anomalies; drug use in pregnancy; epidemiology; teratogens

Indexed keywords

ANALGESIC AGENT; ANTIALLERGIC AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTIRHEUMATIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CALCIUM; CARDIAC AGENT; CONTRACEPTIVE AGENT; CORONARY VASODILATING AGENT; CORTICOSTEROID; CYTOSTATIC AGENT; DIGITALIS; DIURETIC AGENT; FIBRINOLYTIC AGENT; HYPERTENSIVE AGENT; HYPNOTIC SEDATIVE AGENT; IMMUNOSUPPRESSIVE AGENT; INSULIN; SPASMOLYTIC AGENT; TERATOGENIC AGENT; THYROID HORMONE; TUBERCULOSTATIC AGENT; VACCINE; VITAMIN;

ABORTION; ARTICLE; CASE CONTROL STUDY; CENTRAL NERVOUS SYSTEM MALFORMATION; CLEFT LIP; CLEFT PALATE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; FETUS; HUMAN; MAJOR CLINICAL STUDY; MUSCLE MALFORMATION; NEWBORN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; STILLBIRTH; UROGENITAL TRACT MALFORMATION;

ABNORMALITIES, DRUG-INDUCED; ABORTION, INDUCED; ABORTION, SPONTANEOUS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; FETAL DEATH; HUMANS; INCIDENCE; INFANT, NEWBORN; ODDS RATIO; PHARMACEUTICAL PREPARATIONS; PREGNANCY; RISK FACTORS; TERATOGENS;

EID: 0029873144     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960503)63:1<268::AID-AJMG45>3.0.CO;2-J     Document Type: Article

References (69)

1. Bachofen H (1986): Asthma and pregnancy. Schweiz Rundsch Med Prax 75:504-507.
2. Baien A, Kurtz A (1990): Successful outcome of pregnancy with severe hypothyroidism. Case Report and literature review. Br J Obstet Gynecol 97:536-539.
3. Brady K, Duff P (1989): The heart disease in pregnancy: Clin Obstet Gynecol 39:89-102.
4. Brent RL, Beckman DA, Landel CP (1993): Clinical teratology. Curr Opin Pediatr 5:201-211.
5. Breslow NE, Day NE (1980): Statistical methods in cancer research, vol 1, Chapter 3. In: "IARC Scientific Publications, No 32." Lyon: International Agency for Research on cancer.
6. Carson M, Reid M (1976): Warfarin and fetal abnormality. Lancet I: 1127.
7. Carter MP, Wilson F (1963): Antibiotics and congenital malformations. Lancet I:1267.
8. Cockburn J, Ounsted M, Redmann C (1982): Final report of study on hypertension during pregnancy: The effects of specific treatment on the growth and development of children. Lancet I:647-649.
9. Cohen AM, Schenker JG (1972): The effect of insulin treatment on fetal mortality and congenital malformations in diabetic pregnant women. Adv Exp Med Biol 27:377-381.
10. Daw E, Riley S (1984): An unusual congenital abnormality in a diabetic patient's infant. Br J Clin Pract 38:153.
11. Duminy PC, Burger PD (1981): Fetal abnormality associated with the use of captopril during pregnancy. S Afr Med J 60:805-806.
12. EUROCAT Report 6 (1995): "Surveillance of Congenital Anomalies in Europe 1980-1992." Brussels: EUROCAT Central Registry, Institute of Hygiene and Epidemiology, pp 11-26.
13. Fabel G (1988): Exogenous harmful substances in pregnancy and their effects on the embryo and fetus. Zentralbl Gynakol 110:1546-1555.
14. Fraser FC (1988): Thalidomide retrospective: What did we learn? Teratology 38:201-202.
15. Füllgraff G, Palm D (1992): "Pharmakotherapie Klinische Pharmakologie," Stuttgart, Jena, New York: Gustav Fischer Verlag, pp 357-366.
16. Gianopoulos J (1989): Cardiac disease in pregnancy. Med Clin North Am 73:639-651.
17. Greenberger PA, Patterson R (1983): Beclomethasone diproprionate for severe asthma during pregnancy. Ann Intern Med 98:478-480.
18. Hanson J, South O (1975): The fetal hydantoin syndrome. J Pediatr 87:254.
19. Hennekens CH, Burin JE (1987): "Epidemiology in Medicine." Boston, Toronto: Little, Brown and Co., pp 132-152.
20. Hill L, Murphy M, Mcdowall M, Paul AH (1988): Maternal drug histories and congenital malformations. Limb reduction defects and oral clefts. J Epidemiol Community Health 42:1-7.
21. Hodach R, Hodach A, Fallon J (1975): The role of beta-adrenergic activity in the production of cardiac and aortic arch anomalies in chick embryos. Teratology 12:33.
22. International Clearinghouse for Birth Defects Monitoring Systems (1991): "Congenital Malformations Worldwide." Amsterdam, New York, Oxford: Elsevier Science Publishers, pp 35-162.
23. Jick H, Lewis BH, Hunter JR, Madsen S, Tergachis A (1981): First trimester drug use and congenital disorders. JAMA 246:343-346.
24. Jones KL, Lacro RV, Johnson KA, Adams J (1989): Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 320:1661-1666.
25. Kaneko S, Otani K, Fukushima Y, Ogawa Y, Nomura Y, Ono T, Nakane Y, Teranishi T (1988): Teratogenicity of antiepileptic drugs: Analysis of possible risk factors. Epilepsia 29:459-167.
26. Karlsson K, Krantz M, Hamberger L (1980): Comparison of various betamimetics on preterm labour, survival and development of the child. J Perinat Med 8:19.
27. Kelly TE (1984): Teratogenicity of anticonvulsant drugs. I: Review of literature. Am J Med Genet 19:413-434.
28. Kelly TE, Edwards P, Rein M, Miller JO, Dreifuss FE (1984): Teratogenicity of anticonvulsant drugs. II: A prospective study. Am J Med Genet 19:435-443.
29. Khoury MJ, Holtzman NA (1987): On the ability of birth defects monitoring to detect new teratogens. Am J Epidemiol 126:136-143.
30. Khoury MJ, Becerra JE, d'Almada PJ (1989): Maternal thyroid disease and risk of birth defects in offspring: A population based case-control study. Paediatr Perinat Epidemiol 3:402-420.
31. Kitschke HJ, Kümmerle HP (1980): Pharmacotherapy in pregnancy. Part 4: Antidiabetics, antiemetics, neuroleptics and hormones. Munch Med Wochenschr 122:44-15.
32. Klingenberg MA, Papier CM, Hart J (1983): Birth defects monitoring. Am J Ind Med 4:309-328.
33. Knott P, Thorpe S, Lamont C (1989): Congenital renal dysgenesis possibly due to captopril. Lancet 1:451.
34. Kucera J, Lenz W, Mainer W (1965): Malformations of the lower limbs and the caudal part of the spinal column in children of diabetic mothers. Ger Med Mon 10:393-396.
35. Lammer EJ, Codero JF (1986): Exogenous sex hormone exposure and the risk for major malformations. JAMA 255:3128-3132.
36. Lee W, Cotton D (1989): Peripartum cardiomyopathy: Current concepts and clinical management. Clin Obstet Gynecol 32:54-67.
37. Lenz W (1988): A short history of thalidomide embryopathy. Teratology 38:203-215.
38. Levy EP, Cohen A, Fraser FC (1973): Hormone treatment during pregnancy and congenital heart defects. Lancet 1:611.
39. Lindhout D, Omtzigt JG (1994): Teratogenic effects of antiepileptic drugs: Implications for the management of epilepsy in women of childbearing age. Epilepsia [Suppl] 35:19-28.
40. Little BB, Santos-Ramos R (1993): Megadose carbamacepin during the period of neural tube close. Obstet Gynecol 82:705-708.
41. Majewski F (1977): On certain embryopathies induced by teratogenic agents. Monatsschr Kinderheilkd 125:609-620.
42. McDonald AD (1994): Therapeutic drugs in early pregnancy and congenital defects. J Clin Epidemiol 47:105-110.
43. Meadow R (1991): Anticonvulsants in pregnancy. Arch Dis Child 66: 62-65.
44. Miller E, Hare J, Chlohert J (1981): Elevated maternal haemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304:1331-1334.
45. Mills J (1982): Malformations in infants of diabetic mothers. Teratology 25:358-394.
46. Molstedt-Pedersen J (1976): "The Pregnant Diabetic and Her Newborn." Baltimore: Williams and Williams Co.
47. Montella KR (1992): PUlmonary pharmacology in pregnancy. Clin Chest Med 13:587-595.
48. Nora JJ, Nora AH, Blu J, Ingram J, Fountain A, Peterson M, Lortscher RH, Kimberling A (1978): Exogenous progestogen and estrogen implicated in birth defects. JAMA 240:837-843.
49. Opitz JM (1994): Associations and syndromes: Terminology in clinical genetics and birth defects epidemiology. Am J Med Genet 49:14-20.
50. Opitz JM (1995): Pattern formation and malformation. Med Genetik 2:109.
51. Ornoy A, Arnon J (1993): Clinical teratology. West J Med 159: 382-390.
52. Pekonen F, Teramo K, Ikonene E, Osterlund K, Makinene T, Lamberg B (1984): Women on thyroid hormone therapy. Pregnancy course, fetal outcome, and amniotic fluid thyroid hormone level. Obstet Gynecol 63:635.
53. Potter H (1980): Hypothyroidism and reproductive failure. Surg Gynecol Obstet 150:251-255.
54. Quaas L, Siebers JW, Mosa W, Hillemanns HG (1986): Monitoring of pregnancy in diabetes mellitus. Geburtshilfe Frauenheilkd 46:631-636.
55. Queißer-Luft A, Schlaefer K, Schicketanz KH, Spranger J (1994): Erfassung angeborener Fehlbildungen bei Neugeborenen: Das Mainzer Modell. Dtsch Arzteblatt 91:747-750.
56. Rubin JD, Ferencz C, Loffredo C, Baltimore-Washington Study Group (1993): Use of prescription and non-prescription drugs in pregnancy. J Clin Epidemiol 46:581-589.
57. Schwaibold H (1985): Embryopathia and Fetopathia diabetica bei einem unreifen Totgeborenene. Klin Paed 200:135-156.
58. Shepard TH (1986): "Catalog of Teratogenic Agents," 5th ed. Baltimore: John Hopkins University Press.
59. Simons FE (1994): H1-receptor antagonists. Comparative tolerability and safety. Drug Saf May 10:350-380.
60. Simpson JL, Mills JL, Morey A, Metzger BE, Knopp RH, Holmes BL, Jovanovic-Peterson L, Aarons JH, Brown Z, Van Allen M, Elias S (1989): Drug ingestion during pregnancy: Infrequent exposure in a contemporary United States sample. Am J Perinatol 6:244-251.
61. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP, Fiedling DW (1981): Apparent prevention of neural tube defects by periconceptional vitamin supplication. Arch Dis Child 51:911-918.
62. Soler NG, Walsh CH, Malins JM (1976): Congenital malformations in infants of diabetic mothers. Q J Med 45:303-313.
63. Stickler S, Dansky L, Miller M (1985): Genetic predisposition to phenytoin-induced birth defects. Lancet II:76.
64. Treiman DM (1993): Current treatment strategies in selected situations in epilepsy. Epilepsia 34:17-23.
65. Turner ES, Greenberger PA, Patterson R (1980): Management of the pregnant asthmatic patient. Ann Intern Med 93:905-918.
66. Werler MM, Mitchell AA, Shapiro S (1992): First trimester medication use in relation to gastroschisis. Teratology 45:361-367.
67. Wise R (1989): Prescribing in pregnancy: Antibiotics. Br Med J [Clin Res] 294:42.
68. Witter FR, King TM, Blake DA (1981): Adverse effects of cardiovascular drug therapy on the fetus and neonate. Obstet Gynecol [Suppl] 58:100-105.
69. Zackai EH, Mellman WJ, Neiderer B, Hanson JW (1975): The fetal trimethadione syndrome. J Pediatr 87:280-284.